HOW MUCH OF ANTI-CGRP MONOCLONAL ANTIBODY PREVENTIVE THERAPY FOR MIGRAINE IS CONTEXTUAL (PLACEBO) EFFECT?

被引:0
|
作者
Forbes, Raeburn B. [1 ]
McCarron, Mark O. [2 ]
机构
[1] Southern HSC Trust, Portadown, North Ireland
[2] Western HSC Trust, Londonderry, North Ireland
来源
关键词
D O I
10.1136/jnnp-2019-ABN-2.18
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
14.57
引用
下载
收藏
页码:E13 / E13
页数:1
相关论文
共 50 条
  • [1] What Proportion of Anti-CGRP Antibody Therapy for Migraine is Contextual (Placebo) Effect?
    Forbes, Raeburn
    CEPHALALGIA, 2019, 39 : 227 - 228
  • [2] Eptinezumab Anti-CGRP monoclonal antibody Treatment of migraine
    Lu, Lingyun
    Liu, Meijun
    Hu, Songshan
    Liu, Yao
    Yang, Dongdong
    Hong, Peiwei
    DRUGS OF THE FUTURE, 2017, 42 (10) : 609 - 615
  • [3] Placebo And Nocebo Responses In Anti-CGRP Monoclonal Antibody Trials For Migraine Prevention: a meta-analysis
    Kokoti, L.
    Drellia, K.
    Papadopoulos, D.
    Mitsikostas, D. D.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20
  • [4] Patient selection for migraine preventive treatment with anti-CGRP(r) monoclonal antibodies
    Negro, Andrea
    Martelletti, Paolo
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 769 - 776
  • [5] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [6] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [7] Placebo effects in clinical trials of anti-CGRP monoclonal antibodies for migraine prevention
    Regnier, S.
    Lee, X. Ying
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [8] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Giamberardino, Maria Adele
    Affaitati, Giannapia
    Curto, Martina
    Negro, Andrea
    Costantini, Raffaele
    Martelletti, Paolo
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1045 - 1057
  • [9] Anti-CGRP monoclonal antibodies: breakthrough in migraine therapeutics
    Krishnaswamy, Ratna
    Malik, Bilal Haider
    Khan, Safeera
    Gupta, Deepti
    Islam, Muhammad
    Mandel, Shrawan Kumar
    Rutkofsky, Ian H.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2019, 23 (03) : 26 - 33
  • [10] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Maria Adele Giamberardino
    Giannapia Affaitati
    Martina Curto
    Andrea Negro
    Raffaele Costantini
    Paolo Martelletti
    Internal and Emergency Medicine, 2016, 11 : 1045 - 1057